DailyDoctor Archive Specialties Get app
Back to the 14 October 2026 edition

Research · 03 of 05

Remimazolam with flumazenil woke patients faster than propofol, with no later recovery advantage

Remimazolam can speed emergence in short cases, but this trial found no benefit later in recovery.

Design
Prospective, single-blind randomised trial
Population
86 patients having short-duration gynaecological surgery
Primary outcome
Recovery profile: immediate, intermediate and long-term phases
Effect
Eye-opening and extubation shorter with remimazolam (P < 0.001); QoR-15K not significantly different

In this single-blind trial, 86 patients having short gynaecological surgery were randomised to remimazolam or propofol, both with remifentanil. At the end of surgery everyone received sugammadex 2 mg/kg, and the remimazolam group also received flumazenil 200 µg.

Eye-opening and extubation times were significantly shorter with remimazolam (P < 0.001). Time in the post-anaesthesia care unit was longer, which the authors attribute to institutional safety protocols after flumazenil (P < 0.001). Quality of Recovery-15K scores and later recovery measures at 4 hours and 1 day did not differ significantly, though scores were numerically higher with remimazolam.

The faster wake-up is a minutes-scale gain, in a single-blind trial of low-risk patients. It does not show an advantage in the outcomes that patients feel, and the reversal step adds a drug.

  • Remimazolam with flumazenil shortened emergence times compared with propofol.
  • Later recovery quality (QoR-15K at 4 hours and day 1) did not differ significantly.
  • Watch for re-sedation after flumazenil, which is why some units extend recovery observation.
  • Choose the agent on the clinical picture, not on emergence time alone.

Why it matters

Faster emergence is often assumed to equal better recovery, and this trial separates the two.

Don't overread it

Eighty-six low-risk patients in one single-blind trial cannot establish benefit or safety for remimazolam in other settings.

The statistics, in plain English

A very small P value for emergence time tells you the difference is real, not that it matters; the trial reports no difference in the broader recovery score, whose P value was above 0.05 despite higher numbers with remimazolam.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

perioperativeacutepaingeneralanaescardiacanaes

Tomorrow morning, before your first patient

One edition a day for anaesthesiology, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free
Daily Doctor All 27 specialties, every morning. Free.
Get the app